tci Medicare Compliance & Reimbursement - 2023 Issue Q3
Industry Notes: Regulatory Saga for Medicare Coverage of Emerging Tech Continues
Subscribe or sign in to view the full article.
Article Overview
This industry note reviews CMS’s latest notice on transitional coverage for emerging technologies and places it in the context of prior Medicare policy changes involving innovative technology coverage and regulatory reform. It is relevant to readers tracking Medicare coverage policy, FDA breakthrough devices, and the interaction among coverage, coding, and payment review processes. The article also points to the Federal Register notice and the public comment period.
Why This Topic Matters
Policy changes affecting emerging technologies can influence Medicare coverage timing, administrative review, and the path new devices follow from FDA designation to payer access. This note helps stakeholders understand the broader regulatory direction and why the CMS notice matters for coverage planning and reimbursement operations.
What You Will Learn
- How CMS’s approach to Medicare coverage for emerging technologies has changed over time
- What the transitional coverage pathway is intended to address at a high level
- Why coverage, coding, and payment coordination matters for new technologies
- How the CMS notice fits into broader Medicare regulatory reform efforts
Who Should Read This
- Medical coders
- Reimbursement specialists
- Health policy professionals
- Compliance staff
- Device manufacturers
- Clinical administrators
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com